_id
69130ba9ccc777a4e85d7ca6
Ticker
KRRO
Name
Frequency Therapeutics Inc
Exchange
NASDAQ
Address
One Kendall Square, Cambridge, MA, United States, 02139
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.korrobio.com
Description
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. Its lead product candidate is KRRO-110 which is in Phase 1/2 clinical trial for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Last Close
8.08
Volume
149951
Current Price
9.5
Change
0.04
Last Updated
2026-01-04T16:12:14.209Z
Image
data:image/webp;base64,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
Ipo Date
2023-11-06T00:00:00.000Z
Market Cap
75809224
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.6
Target Price
8.6667
Strong Buy
6
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1090000
Cost Of Revenue
-
Gross Profit
1090000
Operating Expenses
20327000
Operating Income
-19237000
Interest Expense
-
Pretax Income
-18061000
Net Income
-18061000
Eps
-1.9231098904878305
Dividends Per Share
-
Shares Outstanding
9417295
Income Tax Expense
-
EBITDA
-16882000
Operating Margin
-1764.862385321101
Total Other Income Expense Net
1176000
Cash
25155000
Short Term Investments
68324000
Receivables
820000
Inventories
-
Total Current Assets
98226000
Property Plant Equipment
47730000
Total Assets
161550000
Payables
2300000
Short Term Debt
3145000
Long Term Debt
-
Total Liabilities
62518000
Equity
99032000
Bs_currency_symbol
USD
Depreciation
1200000
Change In Working Capital
-2253000
Cash From Operations
-17179000
Capital Expenditures
175000
Cash From Investing
7596000
Cash From Financing
128000
Net Change In Cash
-9457000
Cf_currency_symbol
USD
PE
-
PB
0.9009190009289927
ROE
-18.237539381210112
ROA
-11.17982048901269
FCF
-17354000
Fcf Percent
-15.921100917431193
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
3
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1090000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
1090000
Quarters > 0 > income Statement > operating Expenses
20327000
Quarters > 0 > income Statement > operating Income
-19237000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-18061000
Quarters > 0 > income Statement > net Income
-18061000
Quarters > 0 > income Statement > eps
-1.9231098904878305
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
9391559
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-16882000
Quarters > 0 > income Statement > operating Margin
-1764.862385321101
Quarters > 0 > income Statement > total Other Income Expense Net
1176000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
25155000
Quarters > 0 > balance Sheet > short Term Investments
68324000
Quarters > 0 > balance Sheet > receivables
820000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
98226000
Quarters > 0 > balance Sheet > property Plant Equipment
47730000
Quarters > 0 > balance Sheet > total Assets
161550000
Quarters > 0 > balance Sheet > payables
2300000
Quarters > 0 > balance Sheet > short Term Debt
3145000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
62518000
Quarters > 0 > balance Sheet > equity
99032000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-18061000
Quarters > 0 > cash Flow > depreciation
1200000
Quarters > 0 > cash Flow > change In Working Capital
-2253000
Quarters > 0 > cash Flow > cash From Operations
-17179000
Quarters > 0 > cash Flow > capital Expenditures
175000
Quarters > 0 > cash Flow > cash From Investing
7596000
Quarters > 0 > cash Flow > cash From Financing
128000
Quarters > 0 > cash Flow > net Change In Cash
-9457000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.9231098904878305
Quarters > 0 > ratios > PB
0.9009190009289927
Quarters > 0 > ratios > ROE
-18.237539381210112
Quarters > 0 > ratios > ROA
-11.17982048901269
Quarters > 0 > ratios > FCF
-17354000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-15.921100917431193
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1460000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
1460000
Quarters > 1 > income Statement > operating Expenses
28662000
Quarters > 1 > income Statement > operating Income
-27202000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-25769000
Quarters > 1 > income Statement > net Income
-25770000
Quarters > 1 > income Statement > eps
-2.744250544856729
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
9390542
Quarters > 1 > income Statement > income Tax Expense
1000
Quarters > 1 > income Statement > EBITDA
-25975000
Quarters > 1 > income Statement > operating Margin
-1863.150684931507
Quarters > 1 > income Statement > total Other Income Expense Net
1433000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
33612000
Quarters > 1 > balance Sheet > short Term Investments
62750000
Quarters > 1 > balance Sheet > receivables
1089000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
102634000
Quarters > 1 > balance Sheet > property Plant Equipment
48905000
Quarters > 1 > balance Sheet > total Assets
180425000
Quarters > 1 > balance Sheet > payables
5163000
Quarters > 1 > balance Sheet > short Term Debt
2425000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
65322000
Quarters > 1 > balance Sheet > equity
115103000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-25770000
Quarters > 1 > cash Flow > depreciation
1200000
Quarters > 1 > cash Flow > change In Working Capital
3148000
Quarters > 1 > cash Flow > cash From Operations
-19228000
Quarters > 1 > cash Flow > capital Expenditures
140000
Quarters > 1 > cash Flow > cash From Investing
-11300000
Quarters > 1 > cash Flow > cash From Financing
5000
Quarters > 1 > cash Flow > net Change In Cash
-29532000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-2.744250544856729
Quarters > 1 > ratios > PB
0.7750462542244773
Quarters > 1 > ratios > ROE
-22.38864321520725
Quarters > 1 > ratios > ROA
-14.28294305112928
Quarters > 1 > ratios > FCF
-19368000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-13.265753424657534
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
2550000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
2550000
Quarters > 2 > income Statement > operating Expenses
27570000
Quarters > 2 > income Statement > operating Income
-25020000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-23387000
Quarters > 2 > income Statement > net Income
-23387000
Quarters > 2 > income Statement > eps
-2.4921501585739363
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
9384266
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-23795000
Quarters > 2 > income Statement > operating Margin
-981.1764705882354
Quarters > 2 > income Statement > total Other Income Expense Net
1633000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
64144000
Quarters > 2 > balance Sheet > short Term Investments
50809000
Quarters > 2 > balance Sheet > receivables
1924000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
121235000
Quarters > 2 > balance Sheet > property Plant Equipment
50354000
Quarters > 2 > balance Sheet > total Assets
202207000
Quarters > 2 > balance Sheet > payables
4176000
Quarters > 2 > balance Sheet > short Term Debt
2306000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
63250000
Quarters > 2 > balance Sheet > equity
138957000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-23387000
Quarters > 2 > cash Flow > depreciation
1225000
Quarters > 2 > cash Flow > change In Working Capital
-3869000
Quarters > 2 > cash Flow > cash From Operations
-24452000
Quarters > 2 > cash Flow > capital Expenditures
119000
Quarters > 2 > cash Flow > cash From Investing
32781000
Quarters > 2 > cash Flow > cash From Financing
172000
Quarters > 2 > cash Flow > net Change In Cash
8501000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.4921501585739363
Quarters > 2 > ratios > PB
0.6415691688795815
Quarters > 2 > ratios > ROE
-16.830386378519975
Quarters > 2 > ratios > ROA
-11.565870617733314
Quarters > 2 > ratios > FCF
-24571000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-9.635686274509803
Quarters > 2 > health Score
33
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2271000
Quarters > 3 > income Statement > cost Of Revenue
-1447000
Quarters > 3 > income Statement > gross Profit
2271000
Quarters > 3 > income Statement > operating Expenses
25311000
Quarters > 3 > income Statement > operating Income
-23040000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-21096000
Quarters > 3 > income Statement > net Income
-21199000
Quarters > 3 > income Statement > eps
-2.3764200480216435
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
8920561
Quarters > 3 > income Statement > income Tax Expense
103000
Quarters > 3 > income Statement > EBITDA
-21787000
Quarters > 3 > income Statement > operating Margin
-1014.5310435931308
Quarters > 3 > income Statement > total Other Income Expense Net
1944000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
55643000
Quarters > 3 > balance Sheet > short Term Investments
70452000
Quarters > 3 > balance Sheet > receivables
1696000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
131532000
Quarters > 3 > balance Sheet > property Plant Equipment
51546000
Quarters > 3 > balance Sheet > total Assets
226240000
Quarters > 3 > balance Sheet > payables
3992000
Quarters > 3 > balance Sheet > short Term Debt
1284000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
65825000
Quarters > 3 > balance Sheet > equity
160415000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-21199000
Quarters > 3 > cash Flow > depreciation
1253000
Quarters > 3 > cash Flow > change In Working Capital
11177000
Quarters > 3 > cash Flow > cash From Operations
-7495000
Quarters > 3 > cash Flow > capital Expenditures
1452000
Quarters > 3 > cash Flow > cash From Investing
-2765000
Quarters > 3 > cash Flow > cash From Financing
932000
Quarters > 3 > cash Flow > net Change In Cash
-9331999
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-2.3764200480216435
Quarters > 3 > ratios > PB
0.5282880622136333
Quarters > 3 > ratios > ROE
-13.21509833868404
Quarters > 3 > ratios > ROA
-9.370137906647807
Quarters > 3 > ratios > FCF
-8947000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-3.9396741523557903
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2271000
Annuals > 0 > income Statement > cost Of Revenue
3565000
Annuals > 0 > income Statement > gross Profit
2271000
Annuals > 0 > income Statement > operating Expenses
94181000
Annuals > 0 > income Statement > operating Income
-91910000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-83440000
Annuals > 0 > income Statement > net Income
-83581000
Annuals > 0 > income Statement > eps
-9.369477995834567
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
8920561
Annuals > 0 > income Statement > income Tax Expense
141000
Annuals > 0 > income Statement > EBITDA
-88345000
Annuals > 0 > income Statement > operating Margin
-4047.115808014091
Annuals > 0 > income Statement > total Other Income Expense Net
8470000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
55643000
Annuals > 0 > balance Sheet > short Term Investments
70452000
Annuals > 0 > balance Sheet > receivables
1696000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
131532000
Annuals > 0 > balance Sheet > property Plant Equipment
51546000
Annuals > 0 > balance Sheet > total Assets
226240000
Annuals > 0 > balance Sheet > payables
3992000
Annuals > 0 > balance Sheet > short Term Debt
1284000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
65825000
Annuals > 0 > balance Sheet > equity
160415000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-83581000
Annuals > 0 > cash Flow > depreciation
3565000
Annuals > 0 > cash Flow > change In Working Capital
13591000
Annuals > 0 > cash Flow > cash From Operations
-60074000
Annuals > 0 > cash Flow > capital Expenditures
17902000
Annuals > 0 > cash Flow > cash From Investing
-123347000
Annuals > 0 > cash Flow > cash From Financing
69355000
Annuals > 0 > cash Flow > net Change In Cash
-114070000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-9.369477995834567
Annuals > 0 > ratios > PB
0.4476546211389209
Annuals > 0 > ratios > ROE
-52.102982888133894
Annuals > 0 > ratios > ROA
-36.943511315417254
Annuals > 0 > ratios > FCF
-77976000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-34.33553500660502
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3630000
Annuals > 1 > income Statement > gross Profit
-3630000
Annuals > 1 > income Statement > operating Expenses
84534000
Annuals > 1 > income Statement > operating Income
-84534000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-81145000
Annuals > 1 > income Statement > net Income
-81172000
Annuals > 1 > income Statement > eps
-53.07714992470515
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1529321
Annuals > 1 > income Statement > income Tax Expense
27000
Annuals > 1 > income Statement > EBITDA
-80904000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
3389000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
166150000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
172728000
Annuals > 1 > balance Sheet > property Plant Equipment
42815000
Annuals > 1 > balance Sheet > total Assets
221663000
Annuals > 1 > balance Sheet > payables
7280000
Annuals > 1 > balance Sheet > short Term Debt
1991000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
51752000
Annuals > 1 > balance Sheet > equity
169911000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-81172000
Annuals > 1 > cash Flow > depreciation
3630000
Annuals > 1 > cash Flow > change In Working Capital
4283000
Annuals > 1 > cash Flow > cash From Operations
-67283000
Annuals > 1 > cash Flow > capital Expenditures
7836000
Annuals > 1 > cash Flow > cash From Investing
11164000
Annuals > 1 > cash Flow > cash From Financing
187761000
Annuals > 1 > cash Flow > net Change In Cash
131642000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-53.07714992470515
Annuals > 1 > ratios > PB
0.07245578008486796
Annuals > 1 > ratios > ROE
-47.77324599349071
Annuals > 1 > ratios > ROA
-36.61955310538971
Annuals > 1 > ratios > FCF
-75119000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
2511000
Annuals > 2 > income Statement > gross Profit
-2511000
Annuals > 2 > income Statement > operating Expenses
58998000
Annuals > 2 > income Statement > operating Income
-58998000
Annuals > 2 > income Statement > interest Expense
118000
Annuals > 2 > income Statement > pretax Income
-58022000
Annuals > 2 > income Statement > net Income
-58032000
Annuals > 2 > income Statement > eps
-227.4212890027981
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
255174
Annuals > 2 > income Statement > income Tax Expense
10000
Annuals > 2 > income Statement > EBITDA
-56487000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
976000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
36936000
Annuals > 2 > balance Sheet > short Term Investments
18915000
Annuals > 2 > balance Sheet > receivables
449000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
57083000
Annuals > 2 > balance Sheet > property Plant Equipment
11890000
Annuals > 2 > balance Sheet > total Assets
73742000
Annuals > 2 > balance Sheet > payables
2605000
Annuals > 2 > balance Sheet > short Term Debt
2921000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
172773000
Annuals > 2 > balance Sheet > equity
-99031000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-58032000
Annuals > 2 > cash Flow > depreciation
2511000
Annuals > 2 > cash Flow > change In Working Capital
-633000
Annuals > 2 > cash Flow > cash From Operations
-53645000
Annuals > 2 > cash Flow > capital Expenditures
5212000
Annuals > 2 > cash Flow > cash From Investing
11060000
Annuals > 2 > cash Flow > cash From Financing
18000
Annuals > 2 > cash Flow > net Change In Cash
-42567000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-227.4212890027981
Annuals > 2 > ratios > PB
-0.020742501842857287
Annuals > 2 > ratios > ROE
58.59983237572073
Annuals > 2 > ratios > ROA
-78.69599414173742
Annuals > 2 > ratios > FCF
-58857000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
14068000
Annuals > 3 > income Statement > cost Of Revenue
3841000
Annuals > 3 > income Statement > gross Profit
10227000
Annuals > 3 > income Statement > operating Expenses
94258000
Annuals > 3 > income Statement > operating Income
-84031000
Annuals > 3 > income Statement > interest Expense
764000
Annuals > 3 > income Statement > pretax Income
-84671000
Annuals > 3 > income Statement > net Income
-84686000
Annuals > 3 > income Statement > eps
-19.04340004497414
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
4447000
Annuals > 3 > income Statement > income Tax Expense
15000
Annuals > 3 > income Statement > EBITDA
-80066000
Annuals > 3 > income Statement > operating Margin
-597.3201592266137
Annuals > 3 > income Statement > total Other Income Expense Net
-640000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
79635000
Annuals > 3 > balance Sheet > short Term Investments
51072000
Annuals > 3 > balance Sheet > receivables
144000
Annuals > 3 > balance Sheet > inventories
-144000
Annuals > 3 > balance Sheet > total Current Assets
134748000
Annuals > 3 > balance Sheet > property Plant Equipment
36872000
Annuals > 3 > balance Sheet > total Assets
185358000
Annuals > 3 > balance Sheet > payables
2748000
Annuals > 3 > balance Sheet > short Term Debt
2580000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
54534000
Annuals > 3 > balance Sheet > equity
130824000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-21959000
Annuals > 3 > cash Flow > depreciation
1595000
Annuals > 3 > cash Flow > change In Working Capital
904000
Annuals > 3 > cash Flow > cash From Operations
-32094000
Annuals > 3 > cash Flow > capital Expenditures
4447000
Annuals > 3 > cash Flow > cash From Investing
-39501000
Annuals > 3 > cash Flow > cash From Financing
115945000
Annuals > 3 > cash Flow > net Change In Cash
44350000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-19.04340004497414
Annuals > 3 > ratios > PB
0.273637482419128
Annuals > 3 > ratios > ROE
-64.73277074542897
Annuals > 3 > ratios > ROA
-45.687804141175455
Annuals > 3 > ratios > FCF
-36541000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.5974552175149275
Annuals > 3 > health Score
33
Valuation > metrics > PE
-1.9231098904878305
Valuation > metrics > PB
0.9009190009289927
Valuation > final Score
70
Valuation > verdict
9.9% Undervalued
Profitability > metrics > ROE
-18.237539381210112
Profitability > metrics > ROA
-18.387188728035348
Profitability > metrics > Net Margin
-16.569724770642203
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6312908958720413
Risk > metrics > Interest Coverage
-16.31636980491942
Risk > final Score
-17
Risk > verdict
High
Liquidity > metrics > Current Ratio
18.039669421487602
Liquidity > metrics > Quick Ratio
18.039669421487602
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-480
Prev Risks > 1
-185
Prev Risks > 2
-73
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:06:53.362Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-18
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.92
Earnings History > 0 > eps Estimate
-2.6775
Earnings History > 0 > eps Difference
0.7575
Earnings History > 0 > surprise Percent
28.2913
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-2.74
Earnings History > 1 > eps Estimate
-2.17
Earnings History > 1 > eps Difference
-0.57
Earnings History > 1 > surprise Percent
-26.2673
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-2.49
Earnings History > 2 > eps Estimate
-2.6213
Earnings History > 2 > eps Difference
0.1313
Earnings History > 2 > surprise Percent
5.009
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-2.26
Earnings History > 3 > eps Estimate
-2.5129
Earnings History > 3 > eps Difference
0.2529
Earnings History > 3 > surprise Percent
10.0641
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-01
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-2.26
Earnings History > 4 > eps Estimate
-2.61
Earnings History > 4 > eps Difference
0.35
Earnings History > 4 > surprise Percent
13.41
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-2.4287
Earnings History > 5 > eps Estimate
-2.39
Earnings History > 5 > eps Difference
-0.0387
Earnings History > 5 > surprise Percent
-1.6192
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-2.44
Earnings History > 6 > eps Estimate
-2.51
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
2.7888
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-26
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-25.65
Earnings History > 7 > eps Estimate
-2.36
Earnings History > 7 > eps Difference
-23.29
Earnings History > 7 > surprise Percent
-986.8644
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-15.5
Earnings History > 8 > eps Estimate
-17.73
Earnings History > 8 > eps Difference
2.23
Earnings History > 8 > surprise Percent
12.5776
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.3
Earnings History > 9 > eps Estimate
-0.36
Earnings History > 9 > eps Difference
0.06
Earnings History > 9 > surprise Percent
16.6667
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-12
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.55
Earnings History > 10 > eps Estimate
-0.42
Earnings History > 10 > eps Difference
-0.13
Earnings History > 10 > surprise Percent
-30.9524
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-10
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.49
Earnings History > 11 > eps Estimate
-0.631
Earnings History > 11 > eps Difference
0.141
Earnings History > 11 > surprise Percent
22.3455
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.55
Earnings History > 12 > eps Estimate
-0.57
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
3.5088
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.61
Earnings History > 13 > eps Estimate
-0.6633
Earnings History > 13 > eps Difference
0.0533
Earnings History > 13 > surprise Percent
8.0356
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-04
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.67
Earnings History > 14 > eps Estimate
-0.6359
Earnings History > 14 > eps Difference
-0.0341
Earnings History > 14 > surprise Percent
-5.3625
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-15
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.62
Earnings History > 15 > eps Estimate
0.1527
Earnings History > 15 > eps Difference
-0.7727
Earnings History > 15 > surprise Percent
-506.0249
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.73
Earnings History > 16 > eps Estimate
-0.589
Earnings History > 16 > eps Difference
-0.141
Earnings History > 16 > surprise Percent
-23.9389
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.52
Earnings History > 17 > eps Estimate
-0.5086
Earnings History > 17 > eps Difference
-0.0114
Earnings History > 17 > surprise Percent
-2.2414
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.6
Earnings History > 18 > eps Estimate
0.1375
Earnings History > 18 > eps Difference
-0.7375
Earnings History > 18 > surprise Percent
-536.3636
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-29
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.3
Earnings History > 19 > eps Estimate
-0.254
Earnings History > 19 > eps Difference
-0.046
Earnings History > 19 > surprise Percent
-18.1102
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-16
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.16
Earnings History > 20 > eps Estimate
-0.2775
Earnings History > 20 > eps Difference
0.1175
Earnings History > 20 > surprise Percent
42.3423
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-12
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.19
Earnings History > 21 > eps Estimate
-0.19
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-14
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.19
Earnings History > 22 > eps Estimate
-0.17
Earnings History > 22 > eps Difference
-0.02
Earnings History > 22 > surprise Percent
-11.7647
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-26
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.19
Earnings History > 23 > eps Estimate
0.1
Earnings History > 23 > eps Difference
-0.29
Earnings History > 23 > surprise Percent
-290
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-18
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.73
Earnings History > 24 > eps Estimate
-3.42
Earnings History > 24 > eps Difference
2.69
Earnings History > 24 > surprise Percent
78.655
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-28
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-6.67
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-6.67
Earnings History > 25 > surprise Percent
-
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. Its lead product candidate is KRRO-110 which is in Phase 1/2 clinical trial for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AParent and liver doctor join Korro Bio to explain ammonia-driven diseases Stock Titan
Read more →Is World Kinect Corporation stock affected by interest rate hikes - Earnings Risk Report & Free Weekly Chart Analysis and Trade Guides bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$8.6667
Analyst Picks
Strong Buy
6
Buy
4
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Frequency Therapeutics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.92
EPS Estimate
-2.6775
EPS Difference
0.7575
Surprise Percent
28.2913%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.